Total Valuation
Net Medical Xpress Solutions has a market cap or net worth of $26.41K. The enterprise value is $687.37K.
Market Cap$26.41K
Enterprise Value$687.37K
Share Statistics
Net Medical Xpress Solutions has 37,667,580 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding37,667,580
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Net Medical Xpress Solutions’s return on equity (ROE) is 10.04 and return on invested capital (ROIC) is -238.35%.
Return on Equity (ROE)10.04
Return on Assets (ROA)-2.08
Return on Invested Capital (ROIC)-238.35%
Return on Capital Employed (ROCE)-3.76
Revenue Per Employee25.96K
Profits Per Employee-80.74K
Employee Count23
Asset Turnover0.67
Inventory Turnover4.18
Valuation Ratios
The current PE Ratio of Net Medical Xpress Solutions is ―. Net Medical Xpress Solutions’s PEG ratio is 0.00095.
PE Ratio―
PS Ratio0.91
PB Ratio-2.94
Price to Fair Value-2.94
Price to FCF-0.77
Price to Operating Cash Flow-0.04
PEG Ratio0.00095
Income Statement
In the last 12 months, Net Medical Xpress Solutions had revenue of 597.00K and earned -1.86M in profits. Earnings per share was -0.05.
Revenue597.00K
Gross Profit-60.00K
Operating Income-1.82M
Pretax Income-1.86M
Net Income-1.86M
EBITDA-1.70M
Earnings Per Share (EPS)-0.05
Cash Flow
In the last 12 months, operating cash flow was -598.00K and capital expenditures -6.00K, giving a free cash flow of -604.00K billion.
Operating Cash Flow-598.00K
Free Cash Flow-604.00K
Free Cash Flow per Share-0.02
Dividends & Yields
Net Medical Xpress Solutions pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-1.08
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)100.00
Average Volume (3m)2.14K
Important Dates
Net Medical Xpress Solutions upcoming earnings date is Jul 28, 2022, Before Open (Confirmed).
Last Earnings DateInvalid Date
Next Earnings DateJul 28, 2022
Ex-Dividend Date―
Financial Position
Net Medical Xpress Solutions as a current ratio of 1.30, with Debt / Equity ratio of -512.97%
Current Ratio1.30
Quick Ratio0.92
Debt to Market Cap1.71
Net Debt to EBITDA-0.39
Interest Coverage Ratio-42.35
Taxes
In the past 12 months, Net Medical Xpress Solutions has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Net Medical Xpress Solutions EV to EBITDA ratio is -0.71, with an EV/FCF ratio of -1.70.
EV to Sales2.02
EV to EBITDA-0.71
EV to Free Cash Flow-1.70
EV to Operating Cash Flow-1.75
Balance Sheet
Net Medical Xpress Solutions has $159.00K in cash and marketable securities with $926.00K in debt, giving a net cash position of -$767.00K billion.
Cash & Marketable Securities$159.00K
Total Debt$926.00K
Net Cash-$767.00K
Net Cash Per Share-$0.02
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is -10.05%, with operating margin of -305.03%, and net profit margin of -311.06%.
Gross Margin-10.05%
Operating Margin-305.03%
Pretax Margin-311.06%
Net Profit Margin-311.06%
EBITDA Margin-284.42%
EBIT Margin-303.85%
Analyst Forecast
The average price target for Net Medical Xpress Solutions is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―